New research explores the causes of stillbirth by identifying genetic variations in tissue from archived samples, with the goal of identifying biomarkers that may be used in the future for prevention.
Elizabeth McNally, MD, PhD, director of the Center for Genetic Medicine, testified before the U.S. House of Representatives Subcommittee on Research and Technology about the science and ethics of genetically engineered human DNA.
A distinct pattern in the changing lengths of telomeres years before cancer diagnoses could yield a new biomarker that predict cancer, according to a new study.
Northwestern Medicine scientists have for the first time, determined the protective structure of the parainfluenza virus 5 nucleocapsid ring, which…
New Northwestern Medicine research shows spherical nucleic acids can silence a gene that interferes with wound healing, opening the door to new treatments for diabetic skin wounds, as well as many other conditions.
Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM) when delivered using spherical nucleic acid nanoparticles.
Northwestern Medicine scientists have developed a method to systematically explore diverse natural resources, allowing them to quickly identify thousands of compounds from bacteria that have potential to become new pharmaceuticals.
A Northwestern Medicine study has identified new genetic mutations in patients with Wilms tumor, the most common kidney tumor in children.
In several recent publications, Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, examined how different aspects of transcriptional regulation are involved in cancer development.
A new study from Northwestern Medicine and Duke University has identified an enzyme that may be a genetic predictor for whether an expectant mother develops hyperglycemia.